New patent for Neurocrine drug ONGENTYSBy DrugPatentWatch – Make Better Decisions / May 13, 2024 Annual Drug Patent Expirations for ONGENTYS Ongentys is a drug marketed by Neurocrine and is included in one NDA. It is available from two suppliers. There are nine patents protecting…Source